J&J Files 8-K on Financials and Debt Offerings

Ticker: JNJ · Form: 8-K · Filed: 2025-07-16T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, debt-offering, exhibits

Related Tickers: JNJ

TL;DR

J&J dropped an 8-K detailing financials and a bunch of debt notes maturing over the next 30 years.

AI Summary

Johnson & Johnson filed an 8-K on July 16, 2025, reporting on its results of operations and financial condition. The filing includes various exhibits related to its financial statements and debt instruments, such as notes due in 2028, 2029, 2032, 2033, 2035, 2036, 2037, 2044, 2045, and 2055.

Why It Matters

This filing provides insight into Johnson & Johnson's current financial standing and its ongoing debt management strategies, which can influence investor confidence and the company's cost of capital.

Risk Assessment

Risk Level: low — This is a routine filing reporting on financial condition and exhibits, not indicating any immediate adverse events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Johnson & Johnson?

The primary purpose of this 8-K filing is to report on Johnson & Johnson's results of operations and financial condition, and to include financial statements and exhibits.

On what date was this 8-K form filed?

This 8-K form was filed on July 16, 2025.

What types of debt instruments are listed as exhibits in this filing?

The filing lists various notes with different interest rates and maturity dates, including notes due in November 2028, February 2029, November 2032, February 2033, 2035, November 2036, February 2037, November 2044, February 2045, and February 2055.

What is Johnson & Johnson's Standard Industrial Classification (SIC) code?

Johnson & Johnson's SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Where is Johnson & Johnson incorporated?

Johnson & Johnson is incorporated in New Jersey (NJ).

From the Filing

0000200406-25-000170.txt : 20250716 0000200406-25-000170.hdr.sgml : 20250716 20250716080645 ACCESSION NUMBER: 0000200406-25-000170 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250716 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250716 DATE AS OF CHANGE: 20250716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 251126175 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 jnj-20250716.htm 8-K jnj-20250716 0000200406 false 0000200406 2025-07-16 2025-07-16 0000200406 us-gaap:CommonStockMember 2025-07-16 2025-07-16 0000200406 jnj:A1.150NotesDueNovember2028Member 2025-07-16 2025-07-16 0000200406 jnj:A2.700NotesDueFebruary2029Member 2025-07-16 2025-07-16 0000200406 jnj:A3.20NotesDueNovember2032Member 2025-07-16 2025-07-16 0000200406 jnj:A3.050NotesDueFebruary2033Member 2025-07-16 2025-07-16 0000200406 jnj:A1.650NotesDue2035Member 2025-07-16 2025-07-16 0000200406 jnj:A3.350NotesDueNovember2036Member 2025-07-16 2025-07-16 0000200406 jnj:A3.350NotesDueFebruary2037Member 2025-07-16 2025-07-16 0000200406 jnj:A3.550NotesDueNovember2044Member 2025-07-16 2025-07-16 0000200406 jnj:A3.600NotesDueFebruary2045Member 2025-07-16 2025-07-16 0000200406 jnj:A3.700NotesDueFebruary2055Member 2025-07-16 2025-07-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  July 16, 2025 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey    08933   (Address of Principal Executive Offices)  (Zip Code)  Registrant's telephone number, including area code: 732 - 524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 1.150% Notes Due November 2028 JNJ28 New York Stock Exchange 2.700% Notes due February 2029 JNJ29B New York Stock Exchange 3.200% Notes Due June 2032 JNJ32 New Yor

View on Read The Filing